Roskamp Institute Investors LLC is categorized under Commercial Medical Research in Sarasota, FL and active since 2003.
Roskamp Institute Investors LLC was established in 2003, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Commercial Medical Research business, which does work in the B2B market, and is classified as a Commercial Medical Research, under code number 541712 by the NAICS.
If you are seeking more information, feel free to contact Peter Parsonson at the company’s single location by writing to 2040 Whitfield Avenue, Sarasota, Florida FL 34243 or by phoning (941) 752-2949. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Roskamp Institute Investors LLC |
Contact Person: | Peter Parsonson |
Address: | 2040 Whitfield Avenue, Sarasota, Florida 34243 |
Phone Number: | (941) 752-2949 |
Annual Revenue (USD): | $1.000.000 to $2.499.999 |
Founded: | 2003 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Commercial Medical Research |
SIC Code: | 8731 |
NAICS Code: | 541712 |
Share This Business: |
Roskamp Institute Investors LLC was started in 2003 to provide professional Commercial Medical Research under the SIC code 8731 and NAICS code 541712. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Peter Parsonson for inquiries that concern Roskamp Institute Investors LLC by calling the company number (941) 752-2949, as your correspondence is most welcome. Additionally, the physical location of the single location of Roskamp Institute Investors LLC can be found at the coordinates 27.418038,-82.539058 as well as the street address 2040 Whitfield Avenue in Sarasota, Florida 34243.
For its online presence, you may visit Roskamp Institute Investors LLC’s website at and engage with its social media outlets through on Twitter and on Facebook.